Teva Pharmaceutical Industries receives approval for newly revised prescribing information for AZILECT
Links shared publicly online about this topic.
- 1,528total visits
Teva Pharmaceutical Industries receives approval for newly revised prescribing information for AZILECT
Teva Pharmaceutical Industries, Ltd. today announced the U.S. Food and Drug Administration (FDA) approved the newly revised prescribing information for AZILECT® (rasagiline tablets) reducing medication and food restrictions.
View full resource at news-medical.net
Tags: Parkinson's Disease, Disease and Condition, Drug, Pharma, FDA, Teva Pharmaceutical Industries
Most Recently Shared on December 15, 2009 at 9:57 pm By:
Parkinson's Disease: Teva Pharmaceutical Industries receives approval for newly revised prescribing information for... http://bit.ly/4A228i
FDA Approves Newly Revised Prescribing Information For AZILECT(R) Reducing Medication And Food Restrictions
medicalnewstoday.com — “Teva Pharmaceutical Industries, Ltd. (NASDAQ: TEVA) announced the U.S. Food and Drug Administration (FDA) approved the newly revised prescribing information for AZILECT® (rasagiline tablets) r” View full resource at medicalnewstoday.com
Most Recently Shared on December 15, 2009 at 8:11 pm By:
MNT Parkinson's News Health News
FDA Approves Newly Revised Prescribing Information For AZILECT(R) Reducing Medication And Food Restrictions http://mnt.to/3vwn
Advertisement
